Emcure Pharmaceuticals Limited, one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas, has filed its Draft Red Hearing Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI) to raise funds via initial public offering (IPO). It is understood that Emcure Pharma IPO to comprise of fresh issuance of equity shares worth ₹1,100 crore and an offer of sale of 18,168,356 shares.

Leave a Reply

Your email address will not be published. Required fields are marked *